Beyond Ventures, Alibaba inject $312.31m in genetics firm

Prenetics is raising money to use on digital health infrastructure.

Venture capital firm Beyond Ventures and Alibaba Hong Kong Entrepreneurs Fund raised $312.31m (US$40m) to inject in genetics-focused health company Prenetics Limited (Prenetics).

According to a press release, Yuantai Investment Partners, mFund and eGarden Ventures joined the fund's strategic investors.

Prenetics is a genetics-focused digital health company. It said that it is expected to reach $78.08b (US$10b) sales of genetic tests within a decade.

Prenetics has now raised more than $390.39m (US$50m) to build infrastructure that will focus on exploiting big data, machine learning and artificial intelligence as part of an overall health eco-system.

One of its products is a digital health-coaching app which provides individuals with a DNA profile in order to facilitate optimal diet, fitness and response to drugs.

The app also helps users understand their genetic risk of health conditions such as Type 2 Diabetes, High Blood Pressure and High Cholesterol.

Prenetics has launched its products in Hong Kong, Singapore, Malaysia, and Thailand.

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit